BVF PARTNERS L P/IL Insider Trading $ARRY ARRAY BIOPHARMA INC

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for BVF PARTNERS L P/IL.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of BVF PARTNERS L P/IL. BVF PARTNERS L P/IL is in KENT INTERNATIONAL HOLDINGS INC ($CRTQ) and 10% Owner in LIGAND PHARMACEUTICALS INC ($LGND) and 10% Owner in Capstone Therapeutics Corp. ($CAPS) and 10% Owner in REPLIGEN CORP ($RGEN) and 10% Owner in AVIGEN INC \DE ($AVGN) and 10% Owner in NEUROCRINE BIOSCIENCES INC ($NBIX) and 10% Owner in Astex Pharmaceuticals, Inc ($SUPG) and 10% Owner in ARQULE INC ($ARQL) and 10% Owner in NEUROBIOLOGICAL TECHNOLOGIES INC /CA/ ($NTII) and 10% Owner in RIGEL PHARMACEUTICALS INC ($RIGL) and 10% Owner in ARRAY BIOPHARMA INC ($ARRY) and 10% Owner in DYNAVAX TECHNOLOGIES CORP ($DVAX) and 10% Owner in EPIRUS Biopharmaceuticals, Inc. ($CRXX) and 10% Owner in CATALYST BIOSCIENCES, INC. ($CBIO) and 10% Owner in ICAGEN INC ($ICGN) and 10% Owner in ChemoCentryx, Inc. ($CCXI) and 10% Owner in Celera CORP ($CRA) and 10% Owner in ABBOTT BIOTHERAPEUTICS CORP ($FACT).

BVF PARTNERS L P/IL in ARRAY BIOPHARMA INC

Trading Symbol: ARRY
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BVF PARTNERS L P/IL: 10% Owner
Holdings: 4,893,000 shares
Current Value: $51,523,290
Latest Transaction: Dec 05 2011
$ARRY Market Capitalization: $1.80B
$ARRY Previous Close: $10.53

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of BVF PARTNERS L P/IL in ARRAY BIOPHARMA INC

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, FACT, ARQL, ARRY, SUPG, AVGN, CAPS, CBIO, CRA, CCXI, DVAX, CRXX, ICGN, CRTQ, LGND, NTII, NBIX, RGEN, RIGL

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Dec 05 2011	ARRY	ARRAY BIOPHARMA IN ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.14	2,700	5,775	4,893,000	4.9 M to 4.9 M (+0.06 %)
Dec 05 2011	ARRY	ARRAY BIOPHARMA IN ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.14	600	1,283	1,050,900	1.1 M to 1.1 M (+0.06 %)
Dec 05 2011	ARRY	ARRAY BIOPHARMA IN ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.14	1,000	2,139	1,715,269	1.7 M to 1.7 M (+0.06 %)
Dec 05 2011	ARRY	ARRAY BIOPHARMA IN ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.10	20,500	43,034	4,890,300	4.9 M to 4.9 M (+0.42 %)
Dec 05 2011	ARRY	ARRAY BIOPHARMA IN ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.10	4,400	9,236	1,050,300	1 M to 1.1 M (+0.42 %)
Dec 05 2011	ARRY	ARRAY BIOPHARMA IN ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.10	7,200	15,114	1,714,269	1.7 M to 1.7 M (+0.42 %)
Dec 05 2011	ARRY	ARRAY BIOPHARMA IN ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.04	56,400	115,163	4,869,800	4.8 M to 4.9 M (+1.17 %)
Dec 05 2011	ARRY	ARRAY BIOPHARMA IN ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.04	9,200	18,785	1,045,900	1 M to 1 M (+0.89 %)
Dec 05 2011	ARRY	ARRAY BIOPHARMA IN ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.04	17,600	35,937	1,707,069	1.7 M to 1.7 M (+1.04 %)
Dec 05 2011	ARRY	ARRAY BIOPHARMA IN ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.21	38,000	84,029	4,813,400	4.8 M to 4.8 M (+0.80 %)
Dec 05 2011	ARRY	ARRAY BIOPHARMA IN ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.21	11,000	24,324	1,036,700	1 M to 1 M (+1.07 %)
Dec 05 2011	ARRY	ARRAY BIOPHARMA IN ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.21	15,253	33,729	1,689,469	1.7 M to 1.7 M (+0.91 %)

Page: 1